132 related articles for article (PubMed ID: 25225421)
1. Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.
Rachakonda SP; Penack O; Dietrich S; Blau O; Blau IW; Radujkovic A; Isermann B; Ho AD; Uharek L; Dreger P; Kumar R; Luft T
J Clin Oncol; 2014 Oct; 32(30):3421-7. PubMed ID: 25225421
[TBL] [Abstract][Full Text] [Related]
2. Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury.
Li Q; Yang W; Zhao K; Sun X; Bao L
Medicine (Baltimore); 2021 Jul; 100(26):e26293. PubMed ID: 34190147
[TBL] [Abstract][Full Text] [Related]
3. Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation.
Rachakonda SP; Dai H; Penack O; Blau O; Blau IW; Radujkovic A; Müller-Tidow C; Kumar R; Dreger P; Luft T
J Clin Oncol; 2018 Mar; 36(8):789-800. PubMed ID: 29369699
[TBL] [Abstract][Full Text] [Related]
4. A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
Nomoto H; Takami A; Espinoza JL; Matsuo K; Mizuno S; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Nakao S; Ohtake S; Morishita E
Int J Hematol; 2015 Oct; 102(4):460-70. PubMed ID: 26246110
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease.
Kim DH; Lee NY; Lee MH; Sohn SK
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1408-16. PubMed ID: 19041064
[TBL] [Abstract][Full Text] [Related]
6. Multiple single-nucleotide polymorphism-based risk model for clinical outcomes after allogeneic stem-cell transplantation, especially for acute graft-versus-host disease.
Kim DD; Yun J; Won HH; Cheng L; Su J; Xu W; Uhm J; Gupta V; Kuruvilla J; Messner HA; Lipton JH
Transplantation; 2012 Dec; 94(12):1250-7. PubMed ID: 23169244
[TBL] [Abstract][Full Text] [Related]
7. Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses.
Lobato RL; White WD; Mathew JP; Newman MF; Smith PK; McCants CB; Alexander JH; Podgoreanu MV;
Circulation; 2011 Sep; 124(11 Suppl):S143-8. PubMed ID: 21911804
[TBL] [Abstract][Full Text] [Related]
8. Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism.
Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
Clin Appl Thromb Hemost; 2017 May; 23(4):319-328. PubMed ID: 28049360
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
[TBL] [Abstract][Full Text] [Related]
10. Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment.
Dietrich S; Falk CS; Benner A; Karamustafa S; Hahn E; Andrulis M; Hegenbart U; Ho AD; Dreger P; Luft T
Biol Blood Marrow Transplant; 2013 Jan; 19(1):22-7. PubMed ID: 23041600
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
12. Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD.
Inamoto Y; Murata M; Katsumi A; Kuwatsuka Y; Tsujimura A; Ishikawa Y; Sugimoto K; Onizuka M; Terakura S; Nishida T; Kanie T; Taji H; Iida H; Suzuki R; Abe A; Kiyoi H; Matsushita T; Miyamura K; Kodera Y; Naoe T
Bone Marrow Transplant; 2010 Feb; 45(2):363-9. PubMed ID: 19525985
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
[TBL] [Abstract][Full Text] [Related]
14. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.
Thepot S; Zhou J; Perrot A; Robin M; Xhaard A; de Latour RP; Ades L; Ribaud P; Petropoulou AD; Porcher R; Socié G
Leukemia; 2010 Nov; 24(11):1852-8. PubMed ID: 20827288
[TBL] [Abstract][Full Text] [Related]
15. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
[TBL] [Abstract][Full Text] [Related]
16. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
[TBL] [Abstract][Full Text] [Related]
17. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
[TBL] [Abstract][Full Text] [Related]
18. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
[TBL] [Abstract][Full Text] [Related]
19. The association of idiopathic recurrent pregnancy loss with polymorphisms in hemostasis-related genes.
Cao Y; Zhang Z; Xu J; Yuan W; Wang J; Huang X; Shen Y; Du J
Gene; 2013 Nov; 530(2):248-52. PubMed ID: 23954867
[TBL] [Abstract][Full Text] [Related]
20. Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation.
Ambruzova Z; Mrazek F; Raida L; Stahelova A; Faber E; Indrak K; Petrek M
Hum Immunol; 2009 Jun; 70(6):457-60. PubMed ID: 19286444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
